0001683168-22-004784.txt : 20220705 0001683168-22-004784.hdr.sgml : 20220705 20220705213442 ACCESSION NUMBER: 0001683168-22-004784 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220705 DATE AS OF CHANGE: 20220705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Salkind Gene CENTRAL INDEX KEY: 0001592481 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41117 FILM NUMBER: 221067264 MAIL ADDRESS: STREET 1: 1165 WRACK ROAD CITY: MEADOWBROOK STATE: PA ZIP: 19046 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mobiquity Technologies, Inc. CENTRAL INDEX KEY: 0001084267 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ADVERTISING [7310] IRS NUMBER: 113427886 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 TORRINGTON LANE CITY: SHOREHAM STATE: NY ZIP: 11786 BUSINESS PHONE: 516-256-7766 MAIL ADDRESS: STREET 1: 35 TORRINGTON LANE CITY: SHOREHAM STATE: NY ZIP: 11786 FORMER COMPANY: FORMER CONFORMED NAME: ACE MARKETING & PROMOTIONS INC DATE OF NAME CHANGE: 19990414 4 1 ownership.xml X0306 4 2022-06-30 0 0001084267 Mobiquity Technologies, Inc. MOBQ 0001592481 Salkind Gene 35 TORRINGTON LANE SHOREHAM NY 11766 1 0 1 0 Common Stock 2022-06-30 4 C 0 408000 1.25 A 2992354 D Notes 1.25 2022-06-30 4 C 0 510000 D 2019-09-13 2029-09-13 Common Stock 510000 0 D Warrants 4.00 2022-06-30 4 C 0 204000 A 2022-06-30 2029-09-30 Common Stock 204000 1441500 D The 2,992,354 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee. The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust. The board of directors of the issuer accepted Dr. Salkind's offer to convert $510,000 of convertible notes at a reduced conversion price of $1.25 per share into 408,000 common shares and warrants to purchase 204,000 shares at an exercise price of $4.00 per share through September 30, 2029. Not applicable. Left blank intentionally. 1,441,500 derivative securities include the following: (i) 390,625 common stock purchase warrants exercisable at $4.00 per share through September 2023; (ii) 10-year options to purchase 35,000 shares granted on December 8, 2021; and (iii) warrants to purchase 1,015,875 shares exercisable through September 30, 2029 which were issuable on June 30, 2022 as a result of the note conversion. /s/ Gene Salkind 2022-07-05